There are a number of arms to this trial, each taking approx 12-16 weeks with varying doses in each arm (hence the 9 month estimated completion date).
The Fast Track designation they've received will basically open up the door for more frequent meetings / communication with the FDA.
Another box ticked today. GLTA
News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis, page-9
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.2¢ | $8.803K | 275.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1747120 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 324051 | 2 |
View Market Depth
| Last trade - 14.48pm 15/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |